(RYN) Rayonier - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7549071030
Stock: Timber, Land, Real Estate, REIT
Total Rating 39
Risk 98
Buy Signal -1.32
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 10.45% |
| Yield on Cost 5y | 9.87% |
| Yield CAGR 5y | 23.25% |
| Payout Consistency | 93.3% |
| Payout Ratio | 6.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.8% |
| Relative Tail Risk | -9.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.23 |
| Alpha | -12.98 |
| Character TTM | |
|---|---|
| Beta | 0.490 |
| Beta Downside | 0.712 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.28% |
| CAGR/Max DD | -0.24 |
Description: RYN Rayonier January 12, 2026
Rayonier Inc. (NYSE:RYN) is a timberland REIT that, as of June 30 2025, owned or held long-term leases on roughly 2.0 million acres of productive softwood timberlands-about 1.74 million acres in the U.S. South and 307,000 acres in the Pacific Northwest.
Key recent metrics: FY 2024 saw adjusted EBITDA of $1.1 billion, supporting a dividend yield near 6.5%; the company’s timber price index rose ~4 % year-over-year, driven by strong housing starts and lumber demand. A primary sector driver is the long-term upward trend in construction activity, while climate-risk exposure (wildfire and disease) remains a material uncertainty that management mitigates through diversified geography and active forest management.
For a deeper dive into Rayonier’s valuation nuances and how they compare to peers, you might explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 775.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.81 > 1.0 |
| NWC/Revenue: 63.15% < 20% (prev 15.71%; Δ 47.43% < -1%) |
| CFO/TA 0.08 > 3% & CFO 292.7m > Net Income 775.6m |
| Net Debt (141.1m) to EBITDA (511.3m): 0.28 < 3 |
| Current Ratio: 3.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (156.4m) vs 12m ago 3.35% < -2% |
| Gross Margin: 42.85% > 18% (prev 0.30%; Δ 4255 % > 0.5%) |
| Asset Turnover: 31.37% > 50% (prev 25.17%; Δ 6.20% > 0%) |
| Interest Coverage Ratio: 15.36 > 6 (EBITDA TTM 511.3m / Interest Expense TTM 27.1m) |
Altman Z'' 4.63
| A: 0.20 (Total Current Assets 972.9m - Total Current Liabilities 282.6m) / Total Assets 3.49b |
| B: 0.15 (Retained Earnings 514.2m / Total Assets 3.49b) |
| C: 0.12 (EBIT TTM 415.8m / Avg Total Assets 3.49b) |
| D: 1.95 (Book Value of Equity 2.28b / Total Liabilities 1.17b) |
| Altman-Z'' Score: 4.63 = AA |
Beneish M -3.66
| DSRI: 0.33 (Receivables 20.1m/49.4m, Revenue 1.09b/875.7m) |
| GMI: 0.69 (GM 42.85% / 29.55%) |
| AQI: 0.80 (AQ_t 0.71 / AQ_t-1 0.89) |
| SGI: 1.25 (Revenue 1.09b / 875.7m) |
| TATA: 0.14 (NI 775.6m - CFO 292.7m) / TA 3.49b) |
| Beneish M-Score: -3.66 (Cap -4..+1) = AAA |
What is the price of RYN shares?
As of February 07, 2026, the stock is trading at USD 22.46 with a total of 2,441,602 shares traded.
Over the past week, the price has changed by -1.23%, over one month by +2.93%, over three months by +1.42% and over the past year by -5.49%.
Over the past week, the price has changed by -1.23%, over one month by +2.93%, over three months by +1.42% and over the past year by -5.49%.
Is RYN a buy, sell or hold?
Rayonier has received a consensus analysts rating of 3.57.
Therefor, it is recommend to hold RYN.
- StrongBuy: 1
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RYN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.7 | 18.7% |
| Analysts Target Price | 26.7 | 18.7% |
| ValueRay Target Price | 24.6 | 9.7% |
RYN Fundamental Data Overview February 03, 2026
P/E Trailing = 8.6794
P/E Forward = 40.3226
P/S = 2.8664
P/B = 1.601
P/EG = 23.2357
Revenue TTM = 1.09b USD
EBIT TTM = 415.8m USD
EBITDA TTM = 511.3m USD
Long Term Debt = 845.1m USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 1.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 141.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.85b USD (3.71b + Debt 1.06b - CCE 919.6m)
Interest Coverage Ratio = 15.36 (Ebit TTM 415.8m / Interest Expense TTM 27.1m)
EV/FCF = 18.16x (Enterprise Value 3.85b / FCF TTM 211.9m)
FCF Yield = 5.51% (FCF TTM 211.9m / Enterprise Value 3.85b)
FCF Margin = 19.38% (FCF TTM 211.9m / Revenue TTM 1.09b)
Net Margin = 70.94% (Net Income TTM 775.6m / Revenue TTM 1.09b)
Gross Margin = 42.85% ((Revenue TTM 1.09b - Cost of Revenue TTM 624.8m) / Revenue TTM)
Gross Margin QoQ = 32.90% (prev 29.69%)
Tobins Q-Ratio = 1.10 (Enterprise Value 3.85b / Total Assets 3.49b)
Interest Expense / Debt = 0.64% (Interest Expense 6.77m / Debt 1.06b)
Taxrate = 1.14% (500.0k / 43.7m)
NOPAT = 411.0m (EBIT 415.8m * (1 - 1.14%))
Current Ratio = 3.44 (Total Current Assets 972.9m / Total Current Liabilities 282.6m)
Debt / Equity = 0.47 (Debt 1.06b / totalStockholderEquity, last quarter 2.28b)
Debt / EBITDA = 0.28 (Net Debt 141.1m / EBITDA 511.3m)
Debt / FCF = 0.67 (Net Debt 141.1m / FCF TTM 211.9m)
Total Stockholder Equity = 2.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.25% (Net Income 775.6m / Total Assets 3.49b)
RoE = 37.54% (Net Income TTM 775.6m / Total Stockholder Equity 2.07b)
RoCE = 14.28% (EBIT 415.8m / Capital Employed (Equity 2.07b + L.T.Debt 845.1m))
RoIC = 13.14% (NOPAT 411.0m / Invested Capital 3.13b)
WACC = 6.14% (E(3.71b)/V(4.77b) * Re(7.72%) + D(1.06b)/V(4.77b) * Rd(0.64%) * (1-Tc(0.01)))
Discount Rate = 7.72% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.70%
[DCF Debug] Terminal Value 79.49% ; FCFF base≈200.3m ; Y1≈131.5m ; Y5≈60.0m
Fair Price DCF = 10.14 (EV 1.78b - Net Debt 141.1m = Equity 1.64b / Shares 161.4m; r=6.14% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 40.13 | EPS CAGR: 152.0% | SUE: 0.11 | # QB: 0
Revenue Correlation: -30.90 | Revenue CAGR: -9.86% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.08 | Chg30d=-0.060 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.48 | Chg30d=-0.006 | Revisions Net=+0 | Growth EPS=+0.3% | Growth Revenue=-1.4%
P/E Forward = 40.3226
P/S = 2.8664
P/B = 1.601
P/EG = 23.2357
Revenue TTM = 1.09b USD
EBIT TTM = 415.8m USD
EBITDA TTM = 511.3m USD
Long Term Debt = 845.1m USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 1.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 141.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.85b USD (3.71b + Debt 1.06b - CCE 919.6m)
Interest Coverage Ratio = 15.36 (Ebit TTM 415.8m / Interest Expense TTM 27.1m)
EV/FCF = 18.16x (Enterprise Value 3.85b / FCF TTM 211.9m)
FCF Yield = 5.51% (FCF TTM 211.9m / Enterprise Value 3.85b)
FCF Margin = 19.38% (FCF TTM 211.9m / Revenue TTM 1.09b)
Net Margin = 70.94% (Net Income TTM 775.6m / Revenue TTM 1.09b)
Gross Margin = 42.85% ((Revenue TTM 1.09b - Cost of Revenue TTM 624.8m) / Revenue TTM)
Gross Margin QoQ = 32.90% (prev 29.69%)
Tobins Q-Ratio = 1.10 (Enterprise Value 3.85b / Total Assets 3.49b)
Interest Expense / Debt = 0.64% (Interest Expense 6.77m / Debt 1.06b)
Taxrate = 1.14% (500.0k / 43.7m)
NOPAT = 411.0m (EBIT 415.8m * (1 - 1.14%))
Current Ratio = 3.44 (Total Current Assets 972.9m / Total Current Liabilities 282.6m)
Debt / Equity = 0.47 (Debt 1.06b / totalStockholderEquity, last quarter 2.28b)
Debt / EBITDA = 0.28 (Net Debt 141.1m / EBITDA 511.3m)
Debt / FCF = 0.67 (Net Debt 141.1m / FCF TTM 211.9m)
Total Stockholder Equity = 2.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.25% (Net Income 775.6m / Total Assets 3.49b)
RoE = 37.54% (Net Income TTM 775.6m / Total Stockholder Equity 2.07b)
RoCE = 14.28% (EBIT 415.8m / Capital Employed (Equity 2.07b + L.T.Debt 845.1m))
RoIC = 13.14% (NOPAT 411.0m / Invested Capital 3.13b)
WACC = 6.14% (E(3.71b)/V(4.77b) * Re(7.72%) + D(1.06b)/V(4.77b) * Rd(0.64%) * (1-Tc(0.01)))
Discount Rate = 7.72% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.70%
[DCF Debug] Terminal Value 79.49% ; FCFF base≈200.3m ; Y1≈131.5m ; Y5≈60.0m
Fair Price DCF = 10.14 (EV 1.78b - Net Debt 141.1m = Equity 1.64b / Shares 161.4m; r=6.14% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 40.13 | EPS CAGR: 152.0% | SUE: 0.11 | # QB: 0
Revenue Correlation: -30.90 | Revenue CAGR: -9.86% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.08 | Chg30d=-0.060 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.48 | Chg30d=-0.006 | Revisions Net=+0 | Growth EPS=+0.3% | Growth Revenue=-1.4%